Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
Status:
Terminated
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Provide curative immunoreconstituting allogeneic bone marrow transplantation
for patients with primary immunodeficiencies.
II. Determine relevant outcomes of this treatment in these patients including quality of
survival, extent of morbidity and mortality from complications of the treatment (e.g., graft
versus host disease, regimen related toxicities, B- cell lymphoproliferative disease), and
completeness of functional immunoreconstitution.